Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef]
- WHO/ICO Information Center of HPV and Cervical Cancer (HPV Information Center). Human Papillomavirus and Related Diseases Report. Summary Report 2017. Available online: http://www.hpvcentre.net/statistics/reports/XWX.pdf (accessed on 24 June 2018).
- Fitzmaurice, C.; Allen, C.; Barber, R.M.; Barregard, L.; Bhutta, Z.A.; Brenner, H.; Fleming, T. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017, 3, 524–548. [Google Scholar] [CrossRef]
- Fitzmaurice, C.; Dicker, D.; Pain, A.; Hamavid, H.; Moradi-Lakeh, M.; Maclntyre, M.F.; Hamadeh, R.R. The Global Burden of Cancer 2013. Global Burden of Disease Cancer Collaboration. JAMA Oncol. 2015, 1, 505–527. [Google Scholar] [CrossRef] [PubMed]
- Arbyn, M.; Raifu, A.O.; Weiderpass, E.; Bray, F.; Anttila, A. Trends of cervical cancer mortality in the member states of the European Union. Eur. J. Cancer 2009, 45, 2640–2648. [Google Scholar] [CrossRef]
- Wojciechowska, U.; Didkowska, J. Changes in five-year relative survival rates in Poland in patients diagnosed in the years 1999–2010. Nowotw. J. Oncol. 2017, 67, 349–358. [Google Scholar] [CrossRef]
- Sant, M.; Lopez, M.; Agresti, R.; Sánchez Pérez, M.J.; Holleczek, B.; Bielska-Lasota, M.; Dimitrova, N.; Innos, K.; Katalinic, A.; Langseth, H.; et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. Eur. J. Cancer 2015, 51, 2191–2205. [Google Scholar] [CrossRef] [PubMed]
- Torre, L.A.; Islami, F.; Siegel, R.L.; Ward, E.M.; Jemal, A. Global Cancer in Women: Burden and Trends. Cancer Epidemiol. Biomark. Prev. 2017, 26, 444–457. [Google Scholar] [CrossRef]
- Campos, N.G.; Sharma, M.; Clarc, A.; Lee, K.; Geng, F.; Regan, C.; Kim, J.; Resch, S. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries. Int. J. Gynecol. Obstet. 2017, 138, 47–56. [Google Scholar] [CrossRef]
- Penner, D.; Pinheiro, P.; Krämer, A. Measuring the burden of disease due to premature mortality using standard expected years of life lost (SEYLL) in North Rhine-Westphalia, a federal state of Germany, in 2005. J. Public Health 2010, 18, 319–325. [Google Scholar] [CrossRef][Green Version]
- Genova-Maleras, R.; Catala-Lopez, F.; de Larrea-Baz, N.; Alvarez-Martin, E.; Morant-Ginestar, C. The burden of premature mortality in Spain using standard expected years of life lost: A population-based study. BMC Public Health 2011, 11, 787. [Google Scholar] [CrossRef]
- Plass, D.; Kwan Chau, Y.; Thach, T.Q.; Jahn, H.J.; Lai, P.C.; Wong, C.M.; Kraemer, A. Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost. BMC Public Health 2013, 13, 863. [Google Scholar] [CrossRef]
- Castillo-Rodríguez, L.; Díaz-Jiménez, D.; Castañeda-Orjuela, C.; De la Hoz-Restrepo, F. Years of Life Lost (YLL) in Colombia 1998–2011: Overall and avoidable causes of death analysis. PLoS ONE 2015, 10, e0125456. [Google Scholar] [CrossRef]
- Pikala, M.; Maniecka-Bryła, I. Fifteen-year mortality trends in Poland analysed with the use of standard expected years of life lost, 2000–2014. Sci. Rep. 2017, 7, 8730. [Google Scholar] [CrossRef] [PubMed]
- Pikala, M.; Bryla, M.; Bryla, P.; Maniecka-Bryla, I. Years of life lost due to external causes of death in the Lodz province, Poland. PLoS ONE 2014, 9, e96830. [Google Scholar] [CrossRef] [PubMed]
- Revision of the European Standard Population. Available online: https://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa09b3f8f (accessed on 2 June 2018).
- Murray, C.J.; Lopez, A.D. Global Burden of Diseases; University Medical Publishing House Vesalius: Warsaw, Poland, 2000; ISBN 83-85688-63-3. [Google Scholar]
- WHO Methods and Data Sources for Global Burden of Disease Estimates 2000–2011. Available online: https://www.who.int/healthinfo/statistics/GlobalDALYmethods_2000_2011 (accessed on 16 June 2018).
- Marshall, R.J. Standard Expected Years of Life Lost as a measure of disease burden: An investigation of its presentation, meaning and interpretation. In Handbook of Disease Burdens and Quality of Life Measures; Preedy, V.R., Watson, R.R., Eds.; Springer: New York, NY, USA, 2010; pp. 401–413. ISBN 978-0-387-78664-3. [Google Scholar]
- Kim, H.; Fay, M.P.; Feuer, E.J.; Midthune, D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000, 19, 335–351. [Google Scholar] [CrossRef]
- Mackenbach, J.P.; Kunst, A.E. Measuring the magnitude of socio-economic inequalities in health: An overview of available measures illustrated with two examples from Europe. Soc. Sci. Med. 1997, 44, 757–771. [Google Scholar] [CrossRef]
- Goodman, A. HPV testing as a screen for cervical cancer. BMJ Br. Med. J. 2015, 350, h2372. [Google Scholar] [CrossRef]
- Chelimo, C.; Wouldes, T.A.; Cameron, L.D.; Elwood, J.M. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J. Infect. 2013, 66, 207–217. [Google Scholar] [CrossRef]
- Roura, E.; Castellsagué, X.; Pawlita, M.; Travier, N.; Waterboer, T.; Margall, N.; Bosch, F.X.; de Sanjosé, S.; Dillner, J.; Gram, I.T.; et al. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort. Int. J. Cancer 2014, 135, 453–466. [Google Scholar] [CrossRef]
- Lam, J.U.; Rebolj, M.; Dugué, P.A.; Bonde, J.; von Euler-Chelpin, M.; Lynge, E. Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: Systematic review of longitudinal studies. J. Med. Screen. 2014, 21, 38–50. [Google Scholar] [CrossRef]
- Nowakowski, A.; Wojciechowska, U.; Wieszczy, P.; Cybulski, M.; Kamiński, M.; Didkowska, J. Trends in cervical cancer incidence and mortality in Poland: Is there an impact of the introduction of the organised screening? Eur. J. Epidemiol. 2017, 32, 529–532. [Google Scholar] [CrossRef]
- Maniecka-Bryła, I.; Bryła, M.; Bryła, P.; Pikala, M. The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health 2015, 15, 101. [Google Scholar] [CrossRef]
- Ponti, A.; Anttila, A.; Ronco, G.; Senore, C. Cancer Screening in the European Union; International Agency for Research on Cancer: Lyon, France, 2017. [Google Scholar]
- Pikala, M.; Burzynska, M.; Pikala, R.; Bryła, M.; Maniecka-Bryła, I. Educational inequalities in premature mortality in Poland, 2002–2011: A population-based cross-sectional study. BMJ Open 2016, 6, e011501. [Google Scholar] [CrossRef]
- Singh, G.K.; Azuine, R.E.; Siahpush, M. Global Inequalities in Cervical Cancer Incidence and Mortality are Linked to Deprivation, Low Socioeconomic Status, and Human Development. Int. J. MCH AIDS 2012, 1, 17–30. [Google Scholar] [CrossRef]
- Franceschi, S.; Plummer, M.; Clifford, G.; de Sanjose, S.; Bosch, X.; Herrero, R.; Muñoz, N.; Vaccarella, S. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br. J. Cancer 2009, 101, 865–870. [Google Scholar] [CrossRef]
- Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011, 61, 212–236. [Google Scholar] [CrossRef]
- Pikala, M.; Maniecka-Bryła, I. Years of life lost due to malignant neoplasms characterized by the highest mortality rate. Arch. Med. Sci. 2014, 10, 999–1006. [Google Scholar] [CrossRef]
- World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017-recommendations. Vaccine 2017, 35, 5753–5755. [Google Scholar] [CrossRef]
- Cierniak, M. Na co Umarł Pacjent—czyli, co Jest Wpisywane na Kartach Zgonów? Available online: http://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5746/1/1/2/l_na_co_umarl_pacjent.pdf (accessed on 19 March 2019).
Year | Number of Deaths | CDR (per 100,000) | SDR (per 100,000) | SEYLL | SEYLLp (per 100,000) | SEYLLd (per Deaths) |
---|---|---|---|---|---|---|
2000 | 1987 | 10.1 | 12.0 | 55,730 | 394.3 | 28.1 |
2001 | 1826 | 9.3 | 10.8 | 51,128 | 360.0 | 28.0 |
2002 | 1855 | 9.4 | 10.9 | 51,721 | 315.5 | 27.9 |
2003 | 1825 | 9.3 | 10.6 | 50,228 | 304.5 | 27.5 |
2004 | 1819 | 9.3 | 10.3 | 50,501 | 304.3 | 27.8 |
2005 | 1796 | 9.1 | 10.0 | 49,219 | 295.0 | 27.4 |
2006 | 1824 | 9.3 | 10.1 | 48,671 | 290.3 | 26.7 |
2007 | 1907 | 9.7 | 10.5 | 50,294 | 298.9 | 26.4 |
2008 | 1745 | 8.8 | 9.5 | 45,622 | 270.3 | 26.1 |
2009 | 1748 | 8.9 | 9.4 | 45,993 | 271.8 | 26.3 |
2010 | 1735 | 8.7 | 9.1 | 45,310 | 266.2 | 26.1 |
2011 | 1656 | 8.3 | 8.7 | 42,743 | 250.7 | 25.8 |
2012 | 1669 | 8.4 | 8.6 | 42,891 | 251.4 | 25.7 |
2013 | 1669 | 8.4 | 8.5 | 41,455 | 243.1 | 24.8 |
2014 | 1628 | 8.2 | 8.2 | 39,518 | 231.7 | 24.3 |
2015 | 1585 | 8.0 | 7.9 | 37,634 | 220.9 | 23.7 |
Coefficients | Number of Joinpoints | Years | APC (95% CI) | AAPC (95% CI) |
---|---|---|---|---|
CDR | 0 | 2000–2015 | −1.2 * (−8.4; −0.9) | |
SDR | 0 | 2000–2015 | −2.4 * (−2.7; −2.1) | |
SEYLLp | 1 | 2000–2002 | −9.9 * (−16.7; −2.6) | −3.6 * (−4.5; −2.6) |
2002–2015 | −2.6 * (−3.0; −2.2) | |||
SEYLLd | 1 | 2000–2002 | −0.8 * (−1.0; −0,7) | −1.2 * (−1.4; −0.9) |
2002–2015 | −2.6 * (−3.9; −1.2) | |||
SEYLLp according to level of education | ||||
high | 0 | 2000–2015 | −5.4 * (−6.7; −4.0) | |
secondary | 1 | 2000–2002 | −7.3 (−17.7; 4.5) | −1.8 * (−3.2; −0.3) |
2002–2015 | −0.9 * (−1.5; −0.3) | |||
elementary | 1 | 2000–2002 | −11.3 * (−20.1; −1.5) | −3.4 * (−4.6; −2.1) |
2002–2015 | −2.1 * (−2.6; −1.5) | |||
SEYLLp according to place of residence | ||||
urban | 1 | 2000–2002 | −9.1 (−17.9; 0.6) | −3.4 * (−4.7; −2.2) |
2002–2015 | −2.5 * (−3.1; −2.0) | |||
rural | 1 | 2000–2002 | −11.5 (−25.6; 5.2) | −3.8 * (−5.9; −1.7) |
2002–2015 | −2.5 * (−3.4; −1.7) |
Risk Factors | SEYLLp | SR (95% CI) | ||
---|---|---|---|---|
2000 | 2015 | 2000 | 2015 | |
Educational level | ||||
high (ref) | 139.0 | 53.7 | 1.0 | 1.0 |
secondary | 348.1 | 249.6 | 2.5 (2.4; 2.6) | 4.6 (4.4; 4.8) |
elementary | 524.2 | 312.8 | 3.8 (3.6; 4.0) | 5.8 (5.5; 6.1) |
Place of residence | ||||
rural (ref) | 329.5 | 177.7 | 1.0 | 1.0 |
urban | 428.6 | 247.1 | 1.3 (1.2; 1.3) | 1.4. (1.3; 1.4) |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pikala, M.; Burzyńska, M.; Maniecka-Bryła, I. Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015. Int. J. Environ. Res. Public Health 2019, 16, 1545. https://doi.org/10.3390/ijerph16091545
Pikala M, Burzyńska M, Maniecka-Bryła I. Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015. International Journal of Environmental Research and Public Health. 2019; 16(9):1545. https://doi.org/10.3390/ijerph16091545
Chicago/Turabian StylePikala, Małgorzata, Monika Burzyńska, and Irena Maniecka-Bryła. 2019. "Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015" International Journal of Environmental Research and Public Health 16, no. 9: 1545. https://doi.org/10.3390/ijerph16091545
APA StylePikala, M., Burzyńska, M., & Maniecka-Bryła, I. (2019). Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015. International Journal of Environmental Research and Public Health, 16(9), 1545. https://doi.org/10.3390/ijerph16091545